Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Comments

NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols

Anna Bratasz email, Karuppaiyah Selvendiran email, Tomasz Wasowicz email, Andrey Bobko email, Valery V Khramtsov email, Louis J Ignarro email and Periannan Kuppusamy email

Journal of Translational Medicine 2008, 6:9doi:10.1186/1479-5876-6-9

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.